People In The News: Tracking The Latest Industry Personnel Moves
Presidents and CEOs
You may also be interested in...
Pfizer in turn appoints Mikael Dolsten, an ex-Wyeth executive, as its worldwide R&D president.
Management expects clarity from FDA on the clinical development program for two drugs that will help finalize a deal.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011